A critical breakthrough in cancer investigation is emerging with the use of nanobodies to re-engage dysfunctional p53. This crucial tumor inhibitor protein is frequently inactivated in many kinds of malignancies, https://bookmarkuse.com/story21752682/vhh-fragments-reactivate-the-p53-protein-a-promising-hope-for-cancer-treatment